Mikko Airavaara

Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.

In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered.

Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice.

Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra.

Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.

Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA.

WITHDRAWN: Neurorestoration.

CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.

Neurorestoration.

Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors.

Local administration of AAV-BDNF to subventricular zone induces functional recovery in stroke rats.

Short-term preoperative dietary restriction is neuroprotective in a rat focal stroke model.

AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model.

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.

Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.

Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat.

Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.

Update of neurotrophic factors in neurobiology of addiction and future directions.

Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors.

Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.

Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.

AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.

Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra.

Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.

9-cis retinoic acid induces neurorepair in stroke brain.

Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co-maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery.

MANF Promotes Differentiation and Migration of Neural Progenitor Cells with Potential Neural Regenerative Effects in Stroke.

MANF Is Essential for Neurite Extension and Neuronal Migration in the Developing Cortex.

Development and plasticity of meningeal lymphatic vessels.

Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson's Disease.

Differential Spinal and Supraspinal Activation of Glia in a Rat Model of Morphine Tolerance.

The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats.

Towards developing a model to study alcohol drinking and craving in female mice housed in automated cages.

Synthesis of 7β-hydroxy-8-ketone opioid derivatives with antagonist activity at mu- and delta-opioid receptors.

Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury.

Poststroke delivery of MANF promotes functional recovery in rats.

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease.

Implementation of deep neural networks to count dopamine neurons in substantia nigra.

Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.

Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats.

Secondary Pathology of the Thalamus after Focal Cortical Stroke in Rats is not Associated with Thermal or Mechanical Hypersensitivity and is Not Alleviated by Intra-Thalamic Post-Stroke Delivery of Recombinant CDNF or MANF.

Neuroprotective and reparative effects of endoplasmic reticulum luminal proteins - mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor.

Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury.

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra.

Neuronal Activation Stimulates Cytomegalovirus Promoter-Driven Transgene Expression.

Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke.

Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice.

MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine System.

Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.

Molecular profile of the rat peri-infarct region four days after stroke: Study with MANF.

Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microglia.